Abstract
Dr Richard Kim is currently a professor and the chair of the Division of Clinical Pharmacology at Western University and the Director for the Centre for Clinical Investigation and Therapeutics at the London Health Sciences Centre (LHSC). He also holds the Wolfe Medical Research Chair in Pharmacogenomics and is at the forefront of advancing the specialty of clinical pharmacology—a growing field that promises to change the way we deliver healthcare in Canada and abroad. Dr Kim shared his insights into the future of personalized medicine and his roles as a clinician, researcher, administrator, and teacher.
Highlights
UWOMJ: Tell us a bit about yourself and how you came to be a clinical pharmacologist
I was passionate about translating our research to patient care, so along with 2 faculty members and 3 postdoctoral fellows, we took the chance to come to Western in 2006
We look for candidates who have unbridled enthusiasm for translational research and patient care
Summary
Dr Richard Kim is currently a professor and the chair of the Division of Clinical Pharmacology at Western University and the Director for the Centre for Clinical Investigation and Therapeutics at the London Health Sciences Centre (LHSC) He holds the Wolfe Medical Research Chair in Pharmacogenomics and is at the forefront of advancing the specialty of clinical pharmacology—a growing field that promises to change the way we deliver healthcare in Canada and abroad. Our clinical pharmacology residents see many patients on the wards, and every day we are consulted by different subspecialties for whom we do timely genotyping to provide drug therapy recommendations and follow-up care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.